Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

C-MIP Inhibitors

C-MIP inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the C-Maf-inducing protein (C-MIP). C-MIP is a key intracellular protein involved in various cellular signaling pathways, particularly those related to actin cytoskeleton regulation and cellular differentiation. This protein plays a significant role in the modulation of T-cell receptor signaling, impacting various downstream processes that influence cellular behavior, including migration, adhesion, and immune response regulation. By inhibiting C-MIP, these compounds can alter the normal functioning of these pathways, leading to changes in how cells respond to various internal and external signals.

The precise mechanism of C-MIP inhibitors involves binding to the C-MIP protein or its associated complexes, thereby disrupting its role in protein-protein interactions. These inhibitors typically exhibit specificity toward C-MIP, making them valuable tools for studying the molecular pathways influenced by this protein in both normal and abnormal cellular processes. Researchers use C-MIP inhibitors to gain deeper insights into actin dynamics, cell signaling cascades, and other related functions, enabling them to better understand how C-MIP contributes to cellular structure and activity. This class of inhibitors provides a useful chemical approach to dissecting the molecular intricacies of cell behavior and how C-MIP influences these mechanisms on a cellular level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

JAK Inhibitor I

457081-03-7sc-204021
sc-204021A
500 µg
1 mg
$156.00
$339.00
59
(1)

C-MIP is involved in JAK-STAT signaling. By inhibiting JAK3, this compound can indirectly affect C-MIP activity.

Stat3 inhibitor V, stattic

19983-44-9sc-202818
sc-202818A
sc-202818B
sc-202818C
sc-202818D
sc-202818E
sc-202818F
25 mg
100 mg
250 mg
500 mg
1 g
2.5 g
5 g
$130.00
$196.00
$274.00
$512.00
$731.00
$1408.00
$2091.00
114
(3)

Inhibits STAT3 activation, potentially affecting C-MIP function if STAT3 signaling is involved.

AG-490

133550-30-8sc-202046C
sc-202046A
sc-202046B
sc-202046
5 mg
50 mg
25 mg
10 mg
$84.00
$329.00
$223.00
$87.00
35
(1)

Inhibits JAK2, another protein involved in the JAK-STAT pathway, indirectly influencing C-MIP's function.

Stat3 Inhibitor III, WP1066

857064-38-1sc-203282
10 mg
$132.00
72
(1)

Targets STAT3 and JAK2, potentially impacting pathways where C-MIP plays a role.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Another JAK inhibitor that can interfere with JAK-STAT signaling and thereby C-MIP's role in this pathway.

Nifuroxazide

965-52-6sc-204128
sc-204128A
500 mg
5 g
$203.00
$520.00
5
(1)

Inhibits STAT activation and can influence the functions of C-MIP if STAT signaling is implicated.

Baricitinib

1187594-09-7sc-364730
sc-364730A
5 mg
25 mg
$200.00
$664.00
(1)

Yet another JAK inhibitor, targeting JAK1 and JAK2, which can affect C-MIP's associated processes.

Cryptotanshinone

35825-57-1sc-280649
10 mg
$119.00
1
(1)

Known as a STAT3 inhibitor, it might impact C-MIP's function if STAT3 signaling is crucial.

Stat3 Inhibitor VI, S3I-201

501919-59-1sc-204304
10 mg
$151.00
104
(1)

A specific STAT3 inhibitor; can influence C-MIP's role if it's associated with STAT3 signaling.

Janex-1

202475-60-3sc-205354
sc-205354A
1 mg
5 mg
$36.00
$153.00
1
(0)

Targets JAK3, another component of the JAK-STAT pathway. May indirectly affect C-MIP's function in this pathway.